35.26

1.84% -0.66

Newamsterdam Pharma Company Nv (NAMS)

Überblick Nachrichten Preisverlauf Financials Warum fällt NAMS? Forum Prognose

Schlusskurs vom Vortag:

$35.92

Offen:

$36.01

24-Stunden-Volumen:

564.23K

Relative Volume:

0.45

Marktkapitalisierung:

$4.12B

Einnahmen:

$22.57M

Nettoeinkommen (Verlust:

$-212.73M

KGV:

-19.54

EPS:

-1.8045

Netto-Cashflow:

$-142.19M

1W Leistung:

+1.23%

1M Leistung:

+20.22%

6M Leistung:

+2.59%

1J Leistung:

+60.13%

1-Tages-Spanne:

$34.15

$36.17

1-Wochen-Bereich:

$33.81

$37.37

52-Wochen-Spanne:

$20.53

$42.20

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Firmenname

Newamsterdam Pharma Company Nv

Sektor

Healthcare (1096)

Branche

Biotechnology (616)

Telefon

35 206 2971

Adresse

GOOIMEER 2-35, NARRDEN

Mitarbeiter

100

Twitter

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

NAMS's Discussions on Twitter

Compare NAMS vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NAMS Newamsterdam Pharma Company Nv	35.26	4.12B	22.57M	-212.73M	-142.19M	-1.8045
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-18	Eingeleitet	Truist	Buy
2025-10-20	Fortgesetzt	H.C. Wainwright	Buy
2025-08-25	Eingeleitet	Wells Fargo	Overweight
2025-07-17	Eingeleitet	Goldman	Neutral
2025-06-17	Eingeleitet	Citigroup	Buy
2025-06-10	Eingeleitet	Stifel	Buy
2025-06-04	Eingeleitet	Cantor Fitzgerald	Overweight
2024-12-30	Eingeleitet	H.C. Wainwright	Buy
2024-05-15	Eingeleitet	TD Cowen	Buy
2024-03-14	Eingeleitet	Scotiabank	Sector Outperform
2024-01-18	Eingeleitet	Guggenheim	Buy
2024-01-16	Eingeleitet	Piper Sandler	Overweight
2023-10-30	Eingeleitet	RBC Capital Mkts	Outperform

Alle ansehen

Newamsterdam Pharma Company Nv Aktie (NAMS) Neueste Nachrichten

04:21 AM

Price to sales forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

04:21 AM

Jul 08, 2026

Responsive Playbooks and the NAMS Inflection - Stock Traders Daily

Jul 08, 2026

Jul 05, 2026

NewAmsterdam Pharma (NAMS) Alzheimer’s Data Push Puts Fair Value Back In Focus - Sahm

Jul 05, 2026

Jul 03, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Jul 03, 2026

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 - marketscreener.com

Jul 01, 2026

NewAmsterdam Pharma Company N.V. - TradingView

Jul 01, 2026

NewAmsterdam Pharma puts obicetrapib in Alzheimer’s spotlight at AAIC 2026 - Stock Titan

Jul 01, 2026

Jun 28, 2026

Price to sales forward of NewAmsterdam Pharma Company N.V. – BOATS:NAMSW - TradingView

Jun 28, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – BOATS:NAMSW - TradingView

Jun 28, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 28, 2026

Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 28, 2026

Jun 27, 2026

Price to sales forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMSW - TradingView

Jun 27, 2026

Understanding the Setup: (NAMS) and Scalable Risk - Stock Traders Daily

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 27, 2026

Price to book forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 27, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (NASDAQ:NAMS) - TradingView

Jun 27, 2026

NAMS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Jun 26, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (MUN:KH6) - TradingView

Jun 26, 2026

Enterprise value to EBITDA forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 26, 2026

Enterprise value to revenue forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 26, 2026

NewAmsterdam Pharma Company N.V. Actuals & Estimates (LSX:A3DUAC) - TradingView

Jun 26, 2026

Jun 25, 2026

Enterprise value to EBIT forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 25, 2026

NewAmsterdam Pharma (NAMS) Slides 2.76% as Stock Tests Key Support LevelsRounding Bottom - dars.gov.et

Jun 25, 2026

Price to earnings forward of NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS - TradingView

Jun 25, 2026

Jun 24, 2026

NewAmsterdam Pharma (NAMS) CAO exercises options and sells 40,000 shares - Stock Titan

Jun 24, 2026

Price to earnings forward of NewAmsterdam Pharma Company N.V. – LSX:A3DUAC - TradingView

Jun 24, 2026